设计具有延迟治疗效果的临床试验的保证方法
James A Salsbury1, Jeremy E Oakley1, Steven A Julious2
1The School of Mathematics and Statistics, The University of Sheffield, Sheffield, UK.
Statistics in medicine
|June 17, 2024
概括
保证计算,贝叶斯方法,通过设置样本大小来帮助规划临床试验. 这项研究引入了一种新的免疫瘤学试验方法,治疗效果延迟,提高成功率.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 免疫瘤学 免疫瘤学
背景情况:
- 保证计算为临床试验规划提供了贝叶斯的替代传统功率计算.
- 免疫瘤学药物开发通常具有延迟的治疗效果,生存曲线以后会分歧.
- 忽视保证计算中的参数不确定性可能导致样本大小不足和试验失败风险增加.
研究的目的:
- 提出一种新的诱导技术,用于估计延迟治疗效果的试验中的参数.
- 展示如何使用提取的先前分布计算保证.
- 提高第三期免疫瘤学试验的成功率和效率.
主要方法:
- 开发了一种用于延迟治疗效果的新诱导技术.
- 使用提取的先前分布进行计算保证.
- 用实例说明了方法,并开发了开源软件.
主要成果:
- 拟议的方法考虑了对延迟治疗效果至关重要的参数不确定性.
- 证明了实际应用,并提供了用于保证计算的开源软件.
- 该方法可以提高统计能力,减少相关试验的失败风险.
结论:
- 新的保证性计算方法适用于延迟治疗效果的免疫瘤学试验.
- 这种方法有助于确保适当的样本大小,并增加检测临床相关治疗效应的可能性.
- 这些方法有可能优化III期试验的效率和成功率.
相关概念视频
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125


